A report about an ongoing trial of the drug from Raleigh-based Sprout Pharmaceuticals for treatment of low sexual desire in women finds in interim results that the so called ‘female Viagra’ can “be used safely and effectively in women with breast cancer.”
Read More
A startup in Raleigh backed by investor and Pink Ceiling CEO Cindy Eckert, is unveiling Thursday a different approach to dealing with Alzheimer’s that is powered by artificial intelligence, not drugs.
Read More
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals, says the next step in an ongoing debate with the Food and Drug Administration about the firm’s female sexual dysfunction drug Addyi is up to the regulatory agency.
Read More
The U.S. Food and Drug Administration says its discussions with Raleigh-based Sprout Pharmaceuticals about its female sexual dysfunction drug Addyi are intended to avoid “confusion” about any changes in warnings regarding the drug’s use.
Read More
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals is welcoming news that her firm’s so-called “female Viagra” now has competition in the market to deal with female sexual disfunction.
Read More
Three new studies affirm that Addyi, the so-called “female Viagra” from Raleigh based Sprout Pharmaceuticals, is safe and effective with alcohol even though the FDA warns against mixing the two, the company says.
Read More
